<DOC>
	<DOCNO>NCT02712762</DOCNO>
	<brief_summary>This study aim profile ocular surface inflammation chronic Graft-Versus-Host Disease patient investigate conjunctival cell , clinical imaging conjunctival redness tear stability . Hence , investigator expect find increased inflammatory cell population GVHD conjunctival sample .</brief_summary>
	<brief_title>Ocular Surface Disease Chronic Graft-Versus-Host Disease ( GVHD ) Patients</brief_title>
	<detailed_description>Dry eye multi-factorial disease frequently encounter ophthalmological practice . Common dry eye symptom include eye irritation , heaviness eyelid , blur vision light sensitivity ( 1 ) . The worldwide prevalence dry eye generally high ( 2-4 ) . In Asia , dry eye may affect 22 % adult 40 year China ( 5 ) Japan ( 3 ) . In Asian patient older 65 year , prevalence rate dry eye high 80 % diagnosis base abnormal tear stability , high 60 % meibomian gland dysfunction ( MGD ) , major cause tear instability ( 6 ) . Most dry eye patient successfully manage lubricant , punctal occlusion , steroid and/or cyclosporine eye drop . However , patient severe dry eye likely underlying disease example Graft-Versus-Host Disease ( GVHD ) , exhaust conventional treatment may amount 10-20 case year difficult manage . These patient physician helpless face scenario . Hematopoietic stem cell transplantation ( SCT ) establish potential curative therapy hematologic malignancy ( 9 ) . The number SCT recipient increase exponentially worldwide past 2 decade . GVHD major cause morbidity mortality patient undergo allogeneic SCT ( 10 ) . Dry eye associate chronic GVHD one major late complication allogeneic SCT ; significant impact patient ' quality life ( 11-13 ) lead blindness ( 14 ) . The immunological process dry eye associate chronic GVHD remain largely unknown believe traditional alloreactivity recipient tissue . The investigator propose collaborate Singapore General Hospital , Department Haematology focus clinical characteristic immunological profile ocular surface inflammation severe chronic GVHD patient . Dry eye severity severe chronic GVHD patient SNEC , compare idiopathic case dry eye . This may due referral bias , may relate systemic disease . As , investigator intend pilot study define ocular characteristic non-referred haematology patient GVHD . The investigator propose screen recruit 30 suitable participant chronic GVHD . Tests perform include ocular imaging ( Oculus K5M ) , ocular immunological profile ( conjunctiva immune cell ) ocular surface inflammation ( MMP-9 tear marker ) . 1 HYPOTHESIS AND OBJECTIVES This study thus aim profile ocular surface inflammation chronic GVHD patient investigate conjunctival cell , clinical imaging conjunctival redness tear stability . Hence , investigator expect find increased inflammatory cell population GVHD conjunctival sample . Specific aim : 1 . To determine ocular immunological profile ( conjunctival immune cell ) patient GVHD correlate systemic status ( treatment ) . 2 . To determine objective measure tear dysfunction/ ocular surface inflammation abnormal GVHD patient , correlate systemic status . Outcomes : - Dry eye symptom ( SPEED Questionnaire ) - Tear production - Conjunctival immune cell profile ( Proportion T lymphocytes immune cell ) - Clinical parameter ocular surface ( conjunctival redness , non-invasive tear break-up time , corneal fluorescein stain ) Long term aim : 1 . To establish criterion screen cGVH patient referral ophthalmic specialist . 2 . To determine longitudinal outcome cGVH dry eye case , effect systemic prophylactic treatment , well ocular treatment plasmapheresis eye drop . 1.1.1 Potential Risks The investigator anticipate minimal risk discomfort involve study . - It possible may slight discomfort sample conjunctival cell use impression membrane - Some slight discomfort tear Strip Meniscometry - Participants may feel slight irritation InflammaDry test kit administer , require place soft pad make absorbent material participant 's low lid collect tear . - Stinging sensation result local anaesthetic ( Alcaine ) 1.1.2 Potential Benefits With great understand presence various inflammatory mediator , investigator gain insight complex process take place chronic GVHD patient . 2 STUDY POPULATION 3.1 List The Number Nature Subjects Enrolled . Thirty eligible GVHD patient screen recruited Transplant Centre locate Block 7 , Level 1 , Singapore General Hospital- Department Haematology . 3.2 Criteria Recruitment Recruitment Process 1 . Subjects meet inclusion criterion 2 . Clear exclusion criterion . Permission would seek attend doctor SGH , Department Haematology subject recruit . Eligible subject counsel study . If subject interested , informed write consent obtain participant . After , SERI research optometrist proceed ocular examination SGH Transplant Centre . 4 STUDY DESIGN 4.1.1 Study Procedures The examination do SERI study team member . The list require examination show : 1 . Dry Eye Symptoms ( SPEED Questionnaire ) 2 . Non-invasive Tear Break-up Time ( NIKBUT ) - Oculus K5M 3 . Conjunctival Redness- Oculus K5M 4 . Tear Strip Meniscometry ( SMTube ) , Schirmers test 5 . Tear MMP-9 result ( Inflammadry ) 6 . Impression Cytology- use EyePrim conjunctival membrane 7 . Corneal Fluorescein Staining- Oculus K5M Details procedures 1 . Dry Eye Questionnaire Participants ask score dry eye questionnaire assess symptomatic severity dry eye extent disruption daily activity past two week . â€¢ SPEED Questionnaire Consist 2 question frequency severity grade scale 0-3 frequency grade 0-4 severity . The questionnaire allow patient rate 0 never 3 time frequency 0 problem 4 intolerable severity . 2 . Non Invasive Tear Break-up Time ( NIBUT ) The Oculus keratographer 5M ( Oculus , Wetzlar , Germany ) use perform non-invasive tear break time . Patient sit comfortably front instrument blink freely fix target directly ahead . Once patient ready , patient instruct blink twice refrain blink . Keratograph 5M fully automate capture break distortion image time break note . Three reading take eye get average value . It possible tear film participant stable , i.e . increase tear break time . 3 . Imaging conjunctival redness Oculus Keratography 5M 4 . Tear Strip Meniscometry ( SMTube ) Remove SMTube sterile pouch . Hold centre SMTube . Do touch dye area . Immerse tip SMTube lateral low lid tear meniscus eye 5 second . Take extra precaution prevent tip touch patient ' conjunctiva . After 5 second , remove SMTube low lid tear meniscus . Measure length column stain blue colour . 5 . Tear MMP-9 result ( Inflammadry ) The InflammaDry test administer tear meniscometry perform , assess MMP-9 level ( inflammatory marker ) tear hence affect reflex tearing ( 15 ) . The fleece test strip dab along inside line low eyelid multiple location , patient ask blink , strip rest along inferior nasal palpebral conjunctival another 5 second . Assemble sample fleece sample transfer window test cassette body . After absorbent tip immerse buff solution 20 second . Remove absorbent tip buffer vial , replace protective cap , lay test flat horizontal surface 10 minute . A single blue line indicate negative result , appearance 2 line ( red blue ) indicate positive result . 6 . Impression Cytology ( use EyePrim membrane ) ) Preparation RPMI solution In sterile biosafety hood , prepare 2 vial 2ml Eppendorf tube . One tube right eye leave eye respectively . Fill 2 tube 1.5ml RPMI solution . Thereafter , transfer tube ice-box contain ice transfer Transplant Centre locate SGH impression do . ii ) Anaesthesia Step 1 : Inform participant he/she may experience transient sting sensation . Request participant direct gaze upwards . Depress low eyelid place one drop LA inferior palpebral fornix . Do eye . Request patient blink gently least 3 time . Step 2 : Once sting subsides , request participant direct gaze downwards . Elevate patient 's upper eyelid place drop LA bulbar conjunctiva superior point possible . Do eye . Request patient blink gently least 3 time . Step 3 : Repeat step 2 . The participant able feel sting sensation eye point . iii ) Conjunctival sample Step 1 : Request participant direct his/her gaze infero-temporal direction . This expose superior nasal bulbar conjunctiva impression . Step 2 : Apply EyePRIM membrane area . Step 3 : Ensure good apposition membrane conjunctiva . Do rock EyePRIM membrane leave right . Step 4 : Remove membrane conjunctiva peeling-like movement . Step 5 : Exert great force EyePRIM spring mechanism . After `` click '' sound , membrane eject gadget . Place membrane right eye `` right '' eppendorf tube . Step 6 : Repeat superior temporal bulbar conjunctiva , time direct participant 's gaze infero-nasally . Place membrane `` right '' eppendorf tube . There 2 membrane eppendorf tube . Step 7 : Place tube box ice . Step 8 : Repeat step 1-7 eye , place membrane `` leave '' eppendorf tube . Step 9 : At point `` right '' `` leave '' eppendorf tube , 2 membrane within immersed 1.5ml RPMI medium . Place ice box . iv ) Detachment cell membrane Using 10ul micropipette tip , scrape cell membrane . Ensure scrape correct side membrane ( do refer direction hook membrane ) . This easily do pin membrane wall vial tube scrap grinding-like motion ( wall vial tube mortar micropipette tip like pestle ) . Repeat membrane vial tube . Also , repeat step eye . Once scrap cell complete , place 2 eppendorf tube onto ice hand Aihua Tanima ( Academia Level 12 ) FACs analysis day . 7 . Corneal fluorescein stain score</detailed_description>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Graft v Host Disease</mesh_term>
	<criteria>1 . Clinically diagnosed chronic Graft Versus Host Disease ( GVHD ) . 1 . No ocular surgery within last 3 month LASIK within 1 year . 2 . Ocular surface disease pterygium , obvious lid/orbital disease lagophthalmos . 3 . Any specified reason determine clinical investigator .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>immunological profile</keyword>
</DOC>